Dr. Jaiyesimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3577 W 13 Mile Rd
Suite 404
Royal Oak, MI 48073Phone+1 248-551-6991Fax+1 248-551-6910
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 1987 - 1990
College of Osteopathic Medicine of the PacificClass of 1986
Certifications & Licensure
MI State License 1987 - 2027
FL State License 1998 - 2026
TX State License 1990 - 2026
MN State License 1979 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
- Super Doctor SuperDoctors.com
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsRisk of infection and vascular complications with cardiac implantable electronic device implantation in patients with a history of mastectomy.Yong Hao Yeo, Boon Jian San, Jia Yi Tan, Ishmael Jaiyesimi, Nishaki Mehta
Heart Rhythm. 2024-10-01 - 1 citationsTherapy for Stage IV Non-Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights.Dwight H Owen, Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Narjust Florez
JCO Oncology Practice. 2024-07-01 - 10 citationsSystemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Eliza Beal, Richard S Finn
Journal of Clinical Oncology. 2024-05-20
Lectures
- Do Current Antiphospholipid Antibody Syndrome Guidelines Effectively Target at-Risk Obstetric Patients?2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
CAR-T Immunotherapy Now Offered for Blood Cancer Patients at BeaumontOctober 10th, 2022
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
